The assay detects IgM antibodies with high sensitivity and specificity and thus provides a means for the early serological diagnosis of flavivirus infections. It is based on an IgM-capture format and highly purified recombinant viral antigens, allowing the differentiation between infections with antigenically closely related flaviviruses like dengue and Zika viruses. The IgM-capture format is robust, can be easily standardized and readily adapted to existing diagnostic systems for antibody detection.

The diagnostic assay is based on an IgM-capture format and highly purified recombinant viral antigens. It detects antibodies from patient samples and differentiates between infections with antigenically closely related flaviviruses like dengue and Zika viruses or the 4 dengue serotypes.

Innovations offered:

• High specificity and sensitivity Differentiation between dengue and Zika virus infections
• Pure components facilitate production and standardization
• Readily adaptable to existing assay systems
• Global market
• Easy to use for diagnostic laboratories

Currently:

• Assay established in research and routine diagnostic lab

Preferred Cooperation:

□ Commercial Agreement with technical assistance

R Technical Cooperation Agreement

□ Financial Investment Agreement

□ Joint Venture

R Licensing Agreement

□ Manufacturing Agreement

□ Research Collaboration Agreement

□ Services Agreement

Type of Partner sought: